#

Biotechnology

: 131
Abivax shares collapsed nearly 30% after new data on its drug was released / Photo: abivax.com
News·
Shares of biotech Abivax plummet 30% after reports of cancer in trial participants
Redwire shares have more than tripled year to date, now trading 40% above the consensus target price from Wall Street analysts / Photo: X / Redwire
Small Caps·
Small caps last week: Space stocks rally, 'GLP-1 moment for hair loss', LUNR snubbed
Roughly 80 million Americans live with hair loss, while the U.S. Food and Drug Administration last approved a new hair loss treatment 30 years ago, BTIG notes / Photo: Shutterstock.com
Small Caps·
BTIG initiates on Absci as leader of 'GLP-1 moment for hair loss'; stock jumps 18%
As Elon Musk readies SpaceX for a highly anticipated initial public offering, Wall Street is racing to find the next big winner in space exploration, Bloomberg writes / Photo: SpaceX
Small Caps·
Small caps last week: Ebola vaccine, SpaceX IPO beneficiaries, Russell rebalancing
The WHO has declared the outbreak an emergency / Photo: GeoVax
Small Caps·
Ebola outbreak sends shares of vaccine maker GeoVax skyrocketing
GMR specializes in emergency medical care / Photo: GMR
News·
GMR IPO: emergency ambulance service provider goes public
Founded in 2021, Odyssey is developing therapies to treat patients with autoimmune diseases like ulcerative colitis, Crohn’s disease, and lupus / Photo: Odyssey Therapeutics
Small Caps·
Odyssey IPO: Immune system biotech debuts on the Nasdaq
Once the deal closes, Esperion will be delisted from the Nasdaq, which removes a once-public cardiometabolic pure-play from the small-cap biotech universe, notes Noble / Photo: Instagram / Esperioninc
Small Caps·
Small-cap biotech Esperion to be taken private by ARCHIMED; shares jump more than 50%
Small caps last week: Peloton on Spotify, biotech M&A, small-cap ETF leaders
Small Caps·
Small caps last week: Peloton on Spotify, biotech M&A, small-cap ETF leaders
Hemab is developing therapies for blood coagulation disorders such as Glanzmann thrombasthenia and Von Willebrand Disease, according to its filings / Photo: Hemab Therapeutics
Small Caps·
+1
·
Hemab IPO: Novo-backed blood disorder biotech debuts on the Nasdaq
Seaport Therapeutics shares become available / Photo: Seaport Therapeutics
News·
IPO of Seaport Therapeutics: shares of the antidepressant developer become available
KalVista shares soared after a deal with the private Italian pharma company Chiesi / Photo: KalVista
Small Caps·
Small-cap biotech KalVista to be acquired by Italy's Chiesi; stock hits 5-year high
Load more